Niagen Bioscience, Inc. Common Stock NAGE Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total net sales from international sources by Business | |||||
| Analytical Reference Standards and Services segment | $900K0.0% | $900K-10.0% | $1M-23.1% | $1.3M+18.2% | |
| Consumer Products segment | $20.2M+2.0% | $19.8M-7.0% | $21.3M+15.8% | $18.4M+2.2% | |
| Ingredients segment | $6.7M+86.1% | $3.6M+33.3% | $2.7M+28.6% | $2.1M+200% | |
| Gain On Settlement Of Royalty Obligation by Business | |||||
| Analytical Reference Standards and Services segment | $0— | —— | —— | —— | |
| Consumer Products segment | $1.62M— | —— | —— | —— | |
| Ingredients segment | $368K— | —— | —— | —— | |
| Pharmaceuticals segment | $0— | —— | —— | —— | |
| Selling by Business | |||||
| Analytical Reference Standards and Services segment | $347K-30.2% | $497K+37.3% | $362K— | —— | |
| Consumer Products segment | $10.77M+15.9% | $9.29M+10.5% | $8.4M— | —— | |
| Ingredients segment | $144K+260% | $40K-23.1% | $52K— | —— | |
| Marketing by Business | |||||
| Analytical Reference Standards and Services segment | $2K-50.0% | $4K-60.0% | $10K— | —— | |
| Consumer Products segment | $11.49M+37.7% | $8.35M+13.5% | $7.35M— | —— | |
| Ingredients segment | $102K-47.7% | $195K— | $0— | —— | |
| Advertising by Business | |||||
| Analytical Reference Standards and Services segment | $0— | $0— | $0— | —— | |
| Consumer Products segment | $12.66M+14.0% | $11.1M+8.2% | $10.26M— | —— | |
| Ingredients segment | $0— | $0— | $0— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Niagen Bioscience, Inc. Common Stock break its business down?
- Niagen Bioscience, Inc. Common Stock (NAGE) reports net sales by business across 5 parts — Analytical Reference Standards and Services segment, Consumer Products segment, Corporate and other, Ingredients segment and Pharmaceuticals segment. Each is extracted from the segment footnotes and tracked over time.
- Where does Niagen Bioscience, Inc. Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Niagen Bioscience, Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
